Lotte Steuten
- Economics and Econometrics top 1%
- Pulmonary and Respiratory Medicine top 5%
- General Health Professions top 2%
- Epidemiology top 5%
- Oncology top 10%
- Co-authors
- Hubertus JM VrijhoefMaarten J. IJzermanJanne C. MewesWim H. van HartenValesca P. RetèlCor SpreeuwenbergEva C. CreutzbergEmiel F.�M. Wouters
- Topics
- Health Systems, Economic Evaluations, Quality of Life (57 papers)Chronic Disease Management Strategies (16 papers)Economic and Financial Impacts of Cancer (10 papers)
- Cited by
- Applied Microbiology and BiotechnologyEconomics and EconometricsCritical Care and Intensive Care Medicine
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Lotte Steuten
109 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Economics and Econometrics 737
- Pulmonary and Respiratory Medicine 629
- General Health Professions 505
- Epidemiology 493
- Oncology 333
Countries citing papers authored by Lotte Steuten
This map shows the geographic impact of Lotte Steuten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Steuten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Steuten more than expected).
Fields of papers citing papers by Lotte Steuten
This network shows the impact of papers produced by Lotte Steuten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Steuten. The network helps show where Lotte Steuten may publish in the future.
Co-authorship network of co-authors of Lotte Steuten
This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Steuten. A scholar is included among the top collaborators of Lotte Steuten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Steuten. Lotte Steuten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 4 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | Delivering precision oncology to patients with cancerbreakdown → | 197 |
| 11 | 1 | |
| 12 | 33 | |
| 13 | 29 | |
| 14 | 10 | |
| 15 | 41 | |
| 16 | 9 | |
| 17 | 2 | |
| 18 | 12 | |
| 19 | Meta-analysis and meta-regression analyses explaining heterogeneity in outcomes of chronic care management for depression | 0 |
| 20 | 27 |
About Lotte Steuten
Lotte Steuten is a scholar working on Applied Microbiology and Biotechnology, Economics and Econometrics and Issues, ethics and legal aspects, having authored 117 papers that have together received 2.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (57 papers), Chronic Disease Management Strategies (16 papers) and Economic and Financial Impacts of Cancer (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (55 citations), Economics and Econometrics (737 citations) and Critical Care and Intensive Care Medicine (137 citations). Lotte Steuten has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Hubertus JM Vrijhoef, Maarten J. IJzerman, Janne C. Mewes, Wim H. van Harten, Valesca P. Retèl, Cor Spreeuwenberg, Eva C. Creutzberg, Emiel F.�M. Wouters, Martin Buxton and Karin Lemmens. Their work appears in journals such as JAMA, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.